Skip to main content
Isaac Francis Photo
Isaac Francis

Isaac Francis

GrafaFinance Journalist

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.

Articles by Isaac Francis

Grafa

Artiva Biotherapeutics secures FDA alignment for Phase 3 RA trial after strong Phase 2a results

Artiva Biotherapeutics (NASDAQ:ARTV) has reached a pivotal regulatory milestone, securing FDA alignment for a single Phase 3 registrational trial of its lead candidate, AlloNK, following positive initial data in refractory rheumatoid arthritis (RA).

Read more: Artiva Biotherapeutics secures FDA alignment for Phase 3 RA trial after strong Phase 2a results
Grafa

Creative Media & Community Trust reports multifamily growth amid strategic restructuring

Creative Media & Community Trust (NASDAQ:CMCT) reported operating results for the first quarter of 2026, characterized by a dual focus on operational improvement in residential assets and a sweeping overhaul of its capital structure.

Read more: Creative Media & Community Trust reports multifamily growth amid strategic restructuring